| Andriy Pavlenko, MD | |
|
2201 Chapel Ave W, Cherry Hill, NJ 08002-2048 | |
| (856) 488-6560 | |
| (856) 488-6846 |
| Full Name | Andriy Pavlenko |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 30 Years |
| Location | 2201 Chapel Ave W, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932347440 | NPI | - | NPPES |
| 0201529 | Medicaid | NJ | |
| P00755920 | Other | NJ | RAILROAD MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Stratford Hospital | Stratford, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kennedy Medical Group Practice, P.c. | 2860616877 | 321 |
| Coyle S Connolly Do Pa | 2961498118 | 24 |
| Oleg Volchonok, Md, Pc | 4880735125 | 2 |
News Archive
Schering-Plough Corporation has announced the worldwide licensing of acadesine, an investigational, potentially first-in-class adenosine regulating agent (ARA), from PeriCor Therapeutics, Inc., a privately held, specialty biopharmaceutical company.
President Barack Obama's executive order said a working group chaired by Office of National AIDS Policy Director Grant Colfax and Health and Human Services Secretary Kathleen Sebelius would have 180 days to deliver its recommendations.
The July edition of SLAS Discovery is a Special Edition featuring the cover article, "Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry" by Lesley-Anne Pearson, Charlotte J. Green, Ph.D., De Lin, Ph.D., Alain-Pierre Petit, Ph.D., David W. Gray, Ph.D., Victoria H. Cowling, Ph.D., and Euan A. F. Fordyce, Ph.D., (Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, UK).
A new centre at the University of Cambridge, in collaboration with AstraZeneca and GSK, aims to use AI to make medical discoveries, accelerate the development of precision medicine and develop new treatments.
Researchers have developed a powdered form of an anthrax vaccine that could potentially be inhaled through the nose and eliminate the need for needle injections.
› Verified 6 days ago
| Entity Name | Coyle S Connolly Do Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053367516 PECOS PAC ID: 2961498118 Enrollment ID: O20040422001026 |
News Archive
Schering-Plough Corporation has announced the worldwide licensing of acadesine, an investigational, potentially first-in-class adenosine regulating agent (ARA), from PeriCor Therapeutics, Inc., a privately held, specialty biopharmaceutical company.
President Barack Obama's executive order said a working group chaired by Office of National AIDS Policy Director Grant Colfax and Health and Human Services Secretary Kathleen Sebelius would have 180 days to deliver its recommendations.
The July edition of SLAS Discovery is a Special Edition featuring the cover article, "Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry" by Lesley-Anne Pearson, Charlotte J. Green, Ph.D., De Lin, Ph.D., Alain-Pierre Petit, Ph.D., David W. Gray, Ph.D., Victoria H. Cowling, Ph.D., and Euan A. F. Fordyce, Ph.D., (Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, UK).
A new centre at the University of Cambridge, in collaboration with AstraZeneca and GSK, aims to use AI to make medical discoveries, accelerate the development of precision medicine and develop new treatments.
Researchers have developed a powdered form of an anthrax vaccine that could potentially be inhaled through the nose and eliminate the need for needle injections.
› Verified 6 days ago
| Entity Name | Kennedy Medical Group Practice, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952726796 PECOS PAC ID: 2860616877 Enrollment ID: O20140613000689 |
News Archive
Schering-Plough Corporation has announced the worldwide licensing of acadesine, an investigational, potentially first-in-class adenosine regulating agent (ARA), from PeriCor Therapeutics, Inc., a privately held, specialty biopharmaceutical company.
President Barack Obama's executive order said a working group chaired by Office of National AIDS Policy Director Grant Colfax and Health and Human Services Secretary Kathleen Sebelius would have 180 days to deliver its recommendations.
The July edition of SLAS Discovery is a Special Edition featuring the cover article, "Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry" by Lesley-Anne Pearson, Charlotte J. Green, Ph.D., De Lin, Ph.D., Alain-Pierre Petit, Ph.D., David W. Gray, Ph.D., Victoria H. Cowling, Ph.D., and Euan A. F. Fordyce, Ph.D., (Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, UK).
A new centre at the University of Cambridge, in collaboration with AstraZeneca and GSK, aims to use AI to make medical discoveries, accelerate the development of precision medicine and develop new treatments.
Researchers have developed a powdered form of an anthrax vaccine that could potentially be inhaled through the nose and eliminate the need for needle injections.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andriy Pavlenko, MD 2201 Chapel Ave W, Cherry Hill, NJ 08002-2048 Ph: (856) 488-6560 | Andriy Pavlenko, MD 2201 Chapel Ave W, Cherry Hill, NJ 08002-2048 Ph: (856) 488-6560 |
News Archive
Schering-Plough Corporation has announced the worldwide licensing of acadesine, an investigational, potentially first-in-class adenosine regulating agent (ARA), from PeriCor Therapeutics, Inc., a privately held, specialty biopharmaceutical company.
President Barack Obama's executive order said a working group chaired by Office of National AIDS Policy Director Grant Colfax and Health and Human Services Secretary Kathleen Sebelius would have 180 days to deliver its recommendations.
The July edition of SLAS Discovery is a Special Edition featuring the cover article, "Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry" by Lesley-Anne Pearson, Charlotte J. Green, Ph.D., De Lin, Ph.D., Alain-Pierre Petit, Ph.D., David W. Gray, Ph.D., Victoria H. Cowling, Ph.D., and Euan A. F. Fordyce, Ph.D., (Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, UK).
A new centre at the University of Cambridge, in collaboration with AstraZeneca and GSK, aims to use AI to make medical discoveries, accelerate the development of precision medicine and develop new treatments.
Researchers have developed a powdered form of an anthrax vaccine that could potentially be inhaled through the nose and eliminate the need for needle injections.
› Verified 6 days ago
Dr. Jenni M. Davis, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2201 Chapel Ave W, Kennedy Memorial Hospital-umc, Cherry Hill, NJ 08002 Phone: 856-488-6560 Fax: 856-488-6546 | |
Jeanine Chiaffarano, DO Pathology Medicare: Accepting Medicare Assignments Practice Location: 2201 Chapel Ave W, Pathology Department, Cherry Hill, NJ 08002 Phone: 856-488-6560 Fax: 856-488-6624 | |
Janusz Godyn, Pathology Medicare: Medicare Enrolled Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-488-6560 Fax: 856-488-6846 | |
Dr. Richard Bruce Maranoff, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 402 Chanticleer, Cherry Hill, NJ 08003 Phone: 856-751-5589 | |
Jun Liu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2201 Chapel Ave W, Pathology Department, Cherry Hill, NJ 08002 Phone: 856-488-6560 Fax: 856-488-6846 | |
Bethany Lara Mapow, DO Pathology Medicare: Accepting Medicare Assignments Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-488-6500 | |
Darshan B. Roy, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2201 Chapel Ave W, Pathology Department, Cherry Hill, NJ 08002 Phone: 856-488-6560 Fax: 856-488-6846 |